Peach gum polysaccharides promotes epithelial proliferation to attenuate ulcerative colitis by PI3K/AKT pathway

被引:8
作者
Lin, Xiaobo [2 ]
Lan, Mengyao [1 ]
Xu, Cong [2 ]
Pan, Wei [2 ]
Zhang, Chengda [2 ]
Li, Feng [1 ]
Xuan, Weida [2 ]
Chen, Minhua [2 ]
Wang, Hu [3 ]
Huang, Mincong [1 ]
机构
[1] Hangzhou Med Coll, Coll Pharm, 182 Tianmushan Rd, Hangzhou 310013, Zhejiang, Peoples R China
[2] Hangzhou Med Coll, Ctr Safety Evaluat & Res, Hangzhou 310013, Zhejiang, Peoples R China
[3] Hangzhou Hosp Tradit Chinese Med, Hangzhou 310007, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Peach gum polysaccharides; Ulcerative colitis; Cell proliferation; Intestinal barrier; PI3K; AKT pathway; EPIDEMIOLOGY; FRUIT;
D O I
10.1016/j.jff.2023.105662
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Peach gum is a homologous substance of medicine and food, mainly composed of polysaccharides. This study aimed to investigate the effectiveness of Peach gum polysaccharides (PGP) in treatment of ulcerative colitis (UC) and explore its mechanisms. Firstly, we found PGP could decrease the disease activity index, increase length of shortened colon and improve colonic tissue lesions of UC observably in vivo. Further, we explored its mechanisms of anti-UC from aspects of immune regulation and intestinal barrier. On one hand, we found PGP could signif-icantly alleviate inflammation in the colon, but promote the secretion of inflammatory mediators such as IL-6 and TNF-& alpha; by RAW264.7 cells in vitro. It is suggested that PGP does not have direct anti-inflammatory effect. On other hand, we found PGP could increase the ki67 protein to promote the proliferation of colonic epithelial cells in vivo and protect the monolayer barrier function formed by Caco-2 from LPS damage via PI3K/AKT pathway in vitro. In conclusion, PGP could promote the proliferation of colonic epithelial cells via PI3K/AKT pathway to treat UC.
引用
收藏
页数:10
相关论文
共 44 条
[1]  
Araki Y, 2006, ONCOL REP, V16, P1357
[2]   Recent advances in Rosaceae gum exudates: From synthesis to food and non-food applications [J].
Bouaziz, Fatma ;
Koubaa, Mohamed ;
Ghorbel, Raoudha Ellouz ;
Chaabouni, Semia Ellouz .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 86 :535-545
[3]   Treatment Patterns and Sequencing in Patients With Inflammatory Bowel Disease [J].
Brady, Joanne E. ;
Stott-Miller, Marni ;
Mu, George ;
Perera, Sue .
CLINICAL THERAPEUTICS, 2018, 40 (09) :1509-1521
[4]  
Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104
[5]   Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota [J].
Cui, Li ;
Guan, Xueneng ;
Ding, Wenbo ;
Luo, Yi ;
Wang, Wei ;
Bu, Weiquan ;
Song, Jie ;
Tan, Xiaobin ;
Sun, E. ;
Ning, Qing ;
Liu, Guoguang ;
Jia, Xiaobin ;
Feng, Liang .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 166 :1035-1045
[6]   Mannose ameliorates experimental colitis by protecting intestinal barrier integrity [J].
Dong, Lijun ;
Xie, Jingwen ;
Wang, Youyi ;
Jiang, Honglian ;
Chen, Kai ;
Li, Dantong ;
Wang, Jing ;
Liu, Yunzhi ;
He, Jia ;
Zhou, Jia ;
Zhang, Liyun ;
Lu, Xiao ;
Zou, Xiaoming ;
Wang, Xiang-Yang ;
Wang, Qingqing ;
Chen, Zhengliang ;
Zuo, Daming .
NATURE COMMUNICATIONS, 2022, 13 (01)
[7]   Epidemiology and Pathogenesis of Ulcerative Colitis [J].
Du, Lillian ;
Ha, Christina .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2020, 49 (04) :643-+
[8]   Preparation, Structural Analysis and Antioxidant Activity of Polysaccharides and Their Derivatives from Pueraria lobata [J].
Fan, Yumin ;
Huang, Gangliang .
CHEMISTRY & BIODIVERSITY, 2023, 20 (04)
[9]   Emerging therapies for ulcerative colitis [J].
Hanzel, Jurij ;
Hulshoff, Melanie S. ;
Grootjans, Joep ;
D'Haens, Geert .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (05) :513-524
[10]   New Therapeutics for Ulcerative Colitis [J].
Hirten, Robert P. ;
Sands, Bruce E. .
ANNUAL REVIEW OF MEDICINE, VOL 72, 2021, 2021, 72 :199-213